ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -86.4% | 12,076 | -83.1% | 0.00% | – |
Q3 2021 | $154,000 | -36.1% | 71,468 | +3.8% | 0.00% | – |
Q2 2021 | $241,000 | -64.3% | 68,860 | +0.6% | 0.00% | – |
Q1 2021 | $675,000 | -32.7% | 68,455 | -26.0% | 0.00% | – |
Q4 2020 | $1,003,000 | -40.1% | 92,492 | -43.1% | 0.00% | -100.0% |
Q3 2020 | $1,674,000 | -19.1% | 162,438 | +63.9% | 0.00% | 0.0% |
Q2 2020 | $2,070,000 | +314.0% | 99,110 | +93.9% | 0.00% | – |
Q1 2020 | $500,000 | -52.8% | 51,119 | -44.4% | 0.00% | -100.0% |
Q4 2019 | $1,060,000 | +1506.1% | 91,947 | +653.8% | 0.00% | – |
Q3 2019 | $66,000 | -53.8% | 12,197 | +1.6% | 0.00% | – |
Q2 2019 | $143,000 | +120.0% | 12,009 | -3.6% | 0.00% | – |
Q1 2019 | $65,000 | +58.5% | 12,458 | -4.0% | 0.00% | – |
Q4 2018 | $41,000 | -50.0% | 12,974 | -16.7% | 0.00% | – |
Q2 2018 | $82,000 | +134.3% | 15,568 | +29.9% | 0.00% | – |
Q4 2016 | $35,000 | -41.7% | 11,982 | -18.2% | 0.00% | – |
Q3 2016 | $60,000 | -61.8% | 14,647 | -70.5% | 0.00% | – |
Q2 2016 | $157,000 | – | 49,696 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 1,102,735 | $3,485,000 | 3.61% |
VHCP Management II, LLC | 280,000 | $885,000 | 0.53% |
GREAT POINT PARTNERS LLC | 550,116 | $1,738,000 | 0.50% |
JW Asset Management, LLC | 189,919 | $600,000 | 0.48% |
DAFNA Capital Management LLC | 140,600 | $444,000 | 0.35% |
Granite Point Capital Management, L.P. | 186,544 | $589,000 | 0.25% |
SABBY MANAGEMENT, LLC | 779,926 | $2,465,000 | 0.13% |
TFS CAPITAL LLC | 159,364 | $504,000 | 0.09% |
Rhenman & Partners Asset Management AB | 154,006 | $487,000 | 0.09% |
Numeric Investors LLC | 1,134,931 | $3,586,000 | 0.03% |